ResMed (RMD) earnings per share (EPS)

Earnings per share · fiscal 2026
$10.43

ResMed (RMD) reported diluted earnings per share of $10.43 in fiscal 2026 (the year ended June 30, 2026). Figures as of 17 Nov 2026, 20:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2026
$10.43
Growth, 5 years
+26.3% a year
Growth, 10 years
+15.4% a year
Highest on record
$10.43fiscal 2026
Lowest on record
$0.95fiscal 2009
Fiscal years on record
172009–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ResMed earnings per share (EPS), in more detail

Over the five fiscal years to 2026 diluted earnings per share grew at a compound 26.3% a year; over ten years the rate was 15.4% a year. Across the 17 fiscal years on record (2009–2026), the highest was $10.43 in fiscal 2026 and the lowest $0.95 in fiscal 2009.

History · 17 fiscal years

Earnings per share by fiscal year

ResMed earnings per share (EPS), year by year

ResMed (RMD) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2026$10.43—
2024$6.92 13.6% up
2023$6.09 14.9% up
2022$5.30 63.6% up
2021$3.24 24.1% down
2020$4.27 52.5% up
2019$2.80 27.9% up
2018$2.19 8.8% down
2017$2.40 3.6% down
2016$2.49 0.8% up
2015$2.47 3.3% up
2014$2.39 13.8% up
2013$2.10 22.8% up
2012$1.71 18.8% up
2011$1.44 17.1% up
2010$1.23 29.5% up
2009$0.95—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of ResMed and comparable companies
CompanyEarnings per shareFiscal year
Mettler-Toledo International MTD$42.052025
Centene CNC-$13.532025
Genmab GMAB$1.542025
Illumina ILMN$5.452025
ResMed RMD$10.432026
Zoetis ZTS$6.022025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RMD

ResMed, figure by figure

ResMed (RMD) overview: price, valuation and scorecardAll health care companies by market value

ResMed earnings per share (EPS): questions and answers

What is ResMed's diluted earnings per share?

ResMed (RMD) reported diluted earnings per share of $10.43 in fiscal 2026 (the year ended June 30, 2026).

What is the growth rate of ResMed's diluted earnings per share?

Over the five fiscal years to 2026 diluted earnings per share grew at a compound 26.3% a year; over ten years the rate was 15.4% a year.

What are the highest and lowest diluted earnings per share figures on record for ResMed?

Across the 17 fiscal years on record (2009–2026), the highest was $10.43 in fiscal 2026 and the lowest $0.95 in fiscal 2009.

How is ResMed's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ResMed (RMD) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/RMD/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.